OpenVSafe by OpenVAERS
Search V-safe

UN5-38200-88444

3 vaccinations 4 coded responses 20 check-ins 4 free-text entries 0 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
977 / OR
Registered
2021-01-15
Relationship
Self
Race
American Indian or Alaska Native
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-22
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-14
    Dose 2 — Pfizer-BioNTech
  3. 2021-01-15
    Registered in v-safe
  4. 2021-01-15
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain
    Free text: Lymph node swelling
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-01-17
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain · Headache
    Free text: Swollen supraclavicular lymph node
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-01-18
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Supraclavicular lymph node swelling
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-01-23
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  8. 2021-01-28
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  9. 2021-02-04
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  10. 2021-02-11
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  11. 2021-02-18
    Survey response — day 35, dose 2
    MedDRA: Oropharyngeal pain — Feeling: Fair
    Free text: Sore throat
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-02-25
    Health check-in — day 42, dose 2
    Feeling: Fair
    Adult check-in
  13. 2021-04-15
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-07-20
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  15. 2022-01-01
    Dose 3 — Pfizer-BioNTech
  16. 2022-01-14
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in
  17. 2022-01-15
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  18. 2022-01-22
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  19. 2022-01-29
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  20. 2022-02-05
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  21. 2022-02-12
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  22. 2022-04-02
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  23. 2022-07-04
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  24. 2023-01-01
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-22Pfizer-BioNTech
22021-01-14Pfizer-BioNTech
32022-01-01Pfizer-BioNTech No

Free text

Release 2 — days 1–6 daily, dose 2

2021-01-15

Systemic reaction (other): Lymph node swelling

2021-01-17

Systemic reaction (other): Swollen supraclavicular lymph node

2021-01-18

Systemic reaction (other): Supraclavicular lymph node swelling

Release 4 — day 35, dose 2

2021-02-18

Symptoms: Sore throat

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDOropharyngeal pain ✓ ✓ ✓
SROLymphadenopathy ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…